Is There a Role for Molecular Testing for Low-Risk Differentiated Thyroid Cancer? A Cost-Effectiveness Analysis

SIMPLE SUMMARY: Molecular testing for thyroid nodules aims to predict malignancy. However, its role in guiding treatment decisions is not yet fully understood. The long-term nature of thyroid cancer and the relatively high cost of genetic tests have made it challenging to study the use of molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Tessler, Idit, Leshno, Moshe, Feinmesser, Gilad, Alon, Eran E., Avior, Galit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913469/
https://www.ncbi.nlm.nih.gov/pubmed/36765745
http://dx.doi.org/10.3390/cancers15030786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913469/
https://www.ncbi.nlm.nih.gov/pubmed/36765745
http://dx.doi.org/10.3390/cancers15030786

Ejemplares similares